Marinus Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
26.33
|
|
Average Rating
|
4.78
|
|
# Strong Buys
|
7
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
0.47
|
1.89
|
1.42
|
302.13%
|
|
2022-06-30
|
-0.68
|
-1.06
|
-0.38
|
-55.88%
|
|
2022-03-31
|
-0.85
|
-0.52
|
0.33
|
38.82%
|
|
2021-12-31
|
-0.76
|
-0.77
|
-0.01
|
-1.32%
|
|
2021-09-30
|
-0.73
|
-0.53
|
0.20
|
27.40%
|
|
2021-06-30
|
-0.69
|
-0.65
|
0.04
|
5.80%
|
|
2021-03-31
|
-0.45
|
-0.74
|
-0.29
|
-64.44%
|
|
2020-12-31
|
-0.51
|
-0.55
|
-0.04
|
-7.84%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
0.31
|
|
2021-12-31
|
-2.69
|
|
2020-12-31
|
-2.98
|
|
2019-12-31
|
-3.96
|
|
2018-12-31
|
-2.47
|
|
2017-12-31
|
-0.82
|
|
2016-12-31
|
-1.47
|
|
2015-12-31
|
-1.67
|
|
2014-12-31
|
-1.76
|